395 related articles for article (PubMed ID: 29417328)
1. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
[TBL] [Abstract][Full Text] [Related]
2. Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
Xue A; Gandy RC; Chung L; Baxter RC; Smith RC
Pancreatology; 2012; 12(2):124-9. PubMed ID: 22487522
[TBL] [Abstract][Full Text] [Related]
3. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.
Akashi T; Oimomi H; Nishiyama K; Nakashima M; Arita Y; Sumii T; Kimura T; Ito T; Nawata H; Watanabe T
Pancreas; 2003 Jan; 26(1):49-55. PubMed ID: 12499917
[TBL] [Abstract][Full Text] [Related]
4. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas.
Corcos O; Couvelard A; Dargère D; Sauvanet A; Hammel P; Paradis V; Lévy P; Ruszniewski P; Bedossa P
Pancreas; 2012 Mar; 41(2):169-74. PubMed ID: 22076567
[TBL] [Abstract][Full Text] [Related]
5. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
[TBL] [Abstract][Full Text] [Related]
6. [The mistakes in diagnosis of pancreatic intraductal papillary mucinous tumor].
Gorin DS; Zakharova MA; Smirnov AV; Kriger AG
Khirurgiia (Mosk); 2019; (2):96-100. PubMed ID: 30855598
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
8. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
[TBL] [Abstract][Full Text] [Related]
9. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.
Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M
Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670
[TBL] [Abstract][Full Text] [Related]
10. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
[TBL] [Abstract][Full Text] [Related]
11. CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas.
Shimizu K; Itoh T; Shimizu M; Ku Y; Hori Y
Pancreas; 2009 Nov; 38(8):e207-14. PubMed ID: 19786935
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
13. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel antibody associated with autoimmune pancreatitis.
Frulloni L; Lunardi C; Simone R; Dolcino M; Scattolini C; Falconi M; Benini L; Vantini I; Corrocher R; Puccetti A
N Engl J Med; 2009 Nov; 361(22):2135-42. PubMed ID: 19940298
[TBL] [Abstract][Full Text] [Related]
15. Can an intraductal papillary mucinous tumor be a potential indicator of concurrent adenocarcinoma of the pancreas?
Jarry J; Belleannee G; Rault A; Sa Cunha A; Collet D
JOP; 2010 Jan; 11(1):55-7. PubMed ID: 20065554
[TBL] [Abstract][Full Text] [Related]
16. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
17. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
[TBL] [Abstract][Full Text] [Related]
18. Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas.
Fukushima N; Kikuchi Y; Nishiyama T; Kudo A; Fukayama M
Mod Pathol; 2008 Aug; 21(8):1044-53. PubMed ID: 18487994
[TBL] [Abstract][Full Text] [Related]
19. Smallest cystic tumor, measuring 5 mm, was identified as an invasive adenocarcinoma among multiple intraductal papillary-mucinous tumors.
Takagi K; Takada T; Yasuda H; Amano H; Yoshida M; Toyota M; Wada K
Hepatogastroenterology; 2003; 50(53):1341-4. PubMed ID: 14571733
[TBL] [Abstract][Full Text] [Related]
20. Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology.
Ferri MJ; Saez M; Figueras J; Fort E; Sabat M; López-Ben S; de Llorens R; Aleixandre RN; Peracaula R
PLoS One; 2016; 11(1):e0147214. PubMed ID: 26808421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
